Skip to main content
Equibles

Paradigm Biocapital Advisors LP

Position in VRDN — Viridian Therapeutics, Inc.\DE

CIK 1855655 NEW YORK, NY
Back to VRDN Full portfolio

Position in VRDN

as of Jun 30, 2026 · filed Aug 14, 2026
Position Value
$123,515,985
+$61,923,638 QoQ
Shares Held
6,723,788
+113.5% QoQ
Ownership
5.93%
of shares outstanding
% of Portfolio
2.68%
of 13F equity value
Holder Rank
#4
of 215 holders
Holding Since
Dec 2021
19 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in VRDN Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

Paradigm Biocapital Advisors LP holds $4,608,890,546 across 28 Biotechnology names. VRDN ranks #15 (2.7% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RVMD
Revolution Medicines, Inc.
 6,361,323 $1,191,348,571
2 EWTX
Edgewise Therapeutics, Inc.
 10,215,455 $415,053,936
3 GMAB
Genmab A/S
 13,133,131 $360,767,108
4 SYRE
Spyre Therapeutics, Inc.
 3,840,778 $340,984,270
5 APGE
Apogee Therapeutics, Inc.
 1,576,385 $209,233,581
6 ORKA
Oruka Therapeutics, Inc.
 2,144,526 $204,094,539
7 TNGX
Tango Therapeutics, Inc.
 6,357,523 $198,736,168
8 BLTE
Belite Bio, Inc
 1,232,877 $189,844,564

All Filings in VRDN

Export CSV
19 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $123,515,985 6,723,788
2026-03-31 $61,592,347 3,148,893
2025-12-31 $44,909,334 1,443,102
2025-09-30 $56,309,837 2,609,353
2025-06-30 $38,327,232 2,741,576
2025-03-31 $28,241,664 2,095,079
2024-12-31 $34,890,914 1,820,079
2024-09-30 $65,876,924 2,895,689
2024-06-30 $37,681,500 2,896,349
2024-03-31 $88,100,164 5,031,420
2023-12-31 $104,423,948 4,794,488
2023-09-30 $56,477,998 3,681,747
2023-06-30 $57,458,940 2,415,256
2023-03-31 $53,060,157 2,085,698
2022-12-31 $51,151,588 1,751,167
2022-09-30 $33,558,687 1,636,211
2022-06-30 $15,117,003 1,306,569
2022-03-31 $23,224,382 1,256,051
2021-12-31 $23,902,938 1,209,051